126
|
Shin S, Jung M, Song J, Kim J, Park K, Kim J, Lim H, Cho I, Won H, Lee W, Kim S, Kim T, Kim C, Lip GYH. P5350Atrial fibrillation prediction using P wave signal-averaged ECG in patients with embolic stroke of undetermined source. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Approximately 10–25% of ischemic strokes are of unknown origin. Determining their potential association with subclinical atrial fibrillation (SCAF) is important for proper secondary prevention. We investigated whether SCAF can be predicted by assessing the atrial substrate with signal-averaged electrocardiography (SAECG).
Methods
Between April 2015 and February 2018, we recruited 125 consecutive patients with embolic stroke of undetermined source (ESUS) and 125 patients with paroxysmal atrial fibrillation (AF) patients as control. All participants underwent P wave SAECG at baseline and ESUS patients were followed up with ECG and Holter ECG, at baseline, 3, 6, and 12 months after discharge, and every 12 months thereafter.
Results
In the ESUS group (69 males, 68.4±12.1 years), 32 (25.6%) patients were diagnosed with SCAF during follow-up. There were no significant differences between both groups in terms of P wave duration [PWD] (ESUS vs. AF, P=0.321). PWD demonstrated a significant predictive efficacy for SCAF detection during follow-up (C-index of standard PWD=0.657, 95% confidence interval (CI) 0.552–0.761, P=0.008).
Stroke recurrence occurred in 22 patients (17.6%) and was significantly associated with PWD but not SCAF (odds ratio 2.756, 95% CI 1.061–7.161, P=0.037).
Conclusion
PWD, an ECG biomarker associated with atrial substrate directly contributes to AF and ESUS, is useful for predicting SCAF. The potential for using this simple ECG biomarker for screening for SCAF amongst ESUS patients merits further exploration.
Collapse
|
127
|
Ku B, Jung H, Sun J, Lee S, Ahn J, Park K, Ahn M. P1.04-06 Tumor Microenvironment Landscape in Lung Adenocarcinoma by Single-Cell Sequencing. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
128
|
Lee J, Ku B, Shim J, Choi Y, Sun J, Lee S, Ahn J, Park K, Ahn M. P2.14-54 High Incidence of CNS Metastases in Advanced or Recurrent Non-Small Cell Lung Cancer Patients with RET Fusion. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
129
|
Lee S, Pathak K, Mcgilvrey M, Mansfield K, Cridebring D, Roe D, Whitsett T, Pirrotte P, Sun J, Ahn J, Ahn M, Park K. P2.12-14 A Pilot Study of Serial Plasma Metabolomics in Small Cell Lung Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
130
|
Kim J, Kim Y, Park K, Jeong Y, Choi J, Chung SJ, Shin Y, Hong S. Preclinical pharmacokinetic/pharmacodynamic (PK/PD) relationship of ABN401, a highly selective met inhibitor, in gastric and non-small cell lung cancer models. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz238.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
131
|
Ahn M, Park S, Hong S, Park J, Park M, Jung H, Sun J, Lee S, Ahn J, Park K. MA21.10 Phase II Study of 160mg of Osimertinib in EGFR T790M Positive NSCLC with Brain or Leptomeningeal Metastases Who Progressed on Prior EGFR TKI. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.680] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
132
|
Kim Y, Kim C, Lee S, Lee H, Kim H, Kim K, Sun J, Ahn J, Ahn M, Park K. OA14.07 Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
133
|
Ku B, Jung H, Sun J, Lee S, Ahn J, Park K, Ahn M. P2.09-07 Multiple Immunohistochemistry of Non-Small Cell Lung Cancers Reveals Distinct Immune Context. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
134
|
Barlesi F, Özgüroğlu M, Vansteenkiste J, Spigel D, Yang JCH, Bajars M, Ruisi M, Manitz J, Park K. Assessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
135
|
Chae D, Kim SY, Song Y, Baek W, Shin H, Park K, Han DW. Dynamic predictive model for postoperative nausea and vomiting for intravenous fentanyl patient-controlled analgesia. Anaesthesia 2019; 75:218-226. [PMID: 31531854 DOI: 10.1111/anae.14849] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/15/2019] [Indexed: 02/07/2023]
Abstract
Postoperative nausea and vomiting is the most common side-effect of opioid-based intravenous patient-controlled analgesia. Apfel's simplified risk score is popular but it has some limitations. We developed and validated a dynamic predictive model for nausea or vomiting up to 48 postoperative hours, available as an online web application. Fentanyl was used by 22,144 adult patients for analgesia after non-cardiac surgery under general anaesthesia: we randomly divided them into development (80%) and validation (20%) cohorts, repeated 100 times. We used linear discriminant analysis to select variables for multivariate logistic regression. The incidences of postoperative nausea or vomiting were: 0-48 h, 5691/22,144 (26%); 0-6 h, 2749/22,144 (12%); 6-12 h, 2687/22,144 (12%); 12-18 h, 2624/22,144 (12%); 18-24 h, 1884/22,144 (9%); and 24-48 h, 1082/22,144 (5%). The median (95%CI) area under the receiver operating characteristic curve was 0.72 (0.71-0.73) up to 48 postoperative hours compared with 0.65 (0.64-0.66) for the Apfel model, p < 0.001. The equivalent areas for 0-6 h, 6-12 h, 12-18 h, 18-24 h and 24-48 h were: 0.70 (0.69-0.72); 0.71 (0.69-0.73); 0.69 (0.68-0.71); 0.70 (0.67-0.72); and 0.69 (0.66-0.71), respectively. Our web application allows clinicians to calculate incidences of nausea and vomiting in patients receiving intravenous fentanyl for patient-controlled analgesia.
Collapse
|
136
|
Hwang J, An H, Yoon S, Park K. P14.27 The significance of multicentric noncontrast-enhancing lesions distant from surgically resected glioblastoma: Case series of 3 patients. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
BACKGROUND
Glioblastoma is the most malignant primary brain tumor. The tumor location and multiplicity plays an important role in surgical and further treatment. The incidence of multiple lesions at the time of diagnosis was known as 1–20%, which showed a poor prognostic factor. Most researches has focused on multiple contrast-enhancing lesions, however, multicentric non-enhancing lesions distant from glioblastoma has been rarely evaluated. The authors reported the case series of the patient who showed multicentric non contrast-enhancing lesions without connection to histologically-proven glioblastoma.
MATERIAL AND METHODS
Multicentric non contrast-enhancing lesions were defined as areas of FLAIR hyperintensity and mass effect without post-contrast enhancement, separated from the histologically-proven glioblastoma in a newly diagnosed disease. Three patients who showed distant non-enhancing lesions with appearance of a multicentric low-grade glioma were included in this study. The typical enhancing lesions were surgically resected and standard chemo-radiotherapy was followed in all patients.
RESULTS
All patients were male and their age was 38, 60 and 65 years old respectively. Multicentric tumor location was as follows: Case 1, left frontal lobe with non-enhancing lesion in left parahippocampal gyrus; Case 2, left parietal with non-enhancing lesion in left anteromedial temporal lobe; Case 3, left thalamus with non-enhancing lesions in both basal frontal and right temporal lobe. Pathologically, the resected enhancing tumor revealed glioblastoma in 2 patients and diffuse midline glioma in 1. All tumors were IDH-wild type. The resected enhanced lesion showed no progression but all non-enhancing lesions developed contrast-enhancing tumors at 3, 13 and 17 months after initial treatment, with high tracer uptake on 18FDG-PET or 18FDOPA-PET. Despite multidisciplinary treatment, two patients died from disease progression at 30 and 32 months after diagnosis and one patient is still alive with overall survival of 15 months.
CONCLUSION
The appearance of multicentric non-enhancing lesions distant from a typically enhancing tumor showed an uncommon finding in glioblastoma and poor prognostic features. These lesions progress faster than expected for a low-grade glioma. These lesions should be distinguished from typical low-grade glioma and should be considered more advanced lesions than their appearances suggest.
Collapse
|
137
|
Cha J, Kim D, Hong H, Kim G, Park K. Effect of La3+ substitution on the structural and thermoelectric properties of Ca3-La Co4O9+. Ann Ital Chir 2019. [DOI: 10.1016/j.jeurceramsoc.2019.04.030] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
138
|
Shin K, Park H, Kim B, Lee Y, Kim S, Park K. LB1120 Naturally occurring phenolic compounds protect human keratinocytes against diesel exhaust particle-induced cell damage. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.06.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
139
|
Jung J, Park K, Shin SH, Lee JY, Kim MN, Kim SH. The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci. Clin Microbiol Infect 2019; 25:1568-1569. [PMID: 31449869 DOI: 10.1016/j.cmi.2019.08.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2019] [Revised: 08/15/2019] [Accepted: 08/17/2019] [Indexed: 11/28/2022]
|
140
|
Kwon SJ, Park SH, Shin MG, Park MS, Park K, Hong S, Park H, Park YI, Lee JH. Fabrication of high performance and durable forward osmosis membranes using mussel-inspired polydopamine-modified polyethylene supports. J Memb Sci 2019. [DOI: 10.1016/j.memsci.2019.04.074] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
141
|
Nam Y, Park K, Lee S, Ha J, Kim J, Yun H, Han S. SUN-337 ASSOCIATION BETWEEN WEIGHT REDUCTION AND DEVELOPING CARDIOVASCULAR EVENT AMONG THE GENERAL POPULATION. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
142
|
LEE G, Han S, Joo Y, Nam Y, Park K. SAT-257 THE ROLE OF NON-TRADITIONAL RISK FACTORS AND BIOMARKERS IN PREDICTION OF CARDIOVASCULAR EVENTS AND MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE: RESULTS FROM THE KNOW-CKD. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
143
|
Lee S, Nam K, Park K, Ha J, Nam Y, Lee S, Han S. SUN-028 PROGNOSTIC VALUE OF MESANGIAL C3 AND C4d DEPOSITION IN IgA NEPHROPATHY. Kidney Int Rep 2019. [DOI: 10.1016/j.ekir.2019.05.423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
144
|
Duer M, Schmidt A, Pybus JR, Segarra EP, Hrnjic A, Denniston AW, Weiss R, Hen O, Piasetzky E, Weinstein LB, Barnea N, Korover I, Cohen EO, Hakobyan H, Adhikari S, Angelini G, Battaglieri M, Beck A, Bedlinskiy I, Biselli AS, Boiarinov S, Brooks W, Burkert VD, Cao F, Carman DS, Celentano A, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Cortes O, Crede V, Cruz Torres R, D'Angelo A, Dashyan N, De Sanctis E, De Vita R, Deur A, Diehl S, Djalali C, Dupre R, Duran B, Egiyan H, El Alaoui A, El Fassi L, Eugenio P, Filippi A, Forest TA, Gilfoyle GP, Giovanetti KL, Girod FX, Golovatch E, Gothe RW, Griffioen KA, Guo L, Hafidi K, Hanretty C, Harrison N, Hattawy M, Hauenstein F, Hayward TB, Heddle D, Hicks K, Holtrop M, Ilieva Y, Ireland DG, Ishkhanov BS, Isupov EL, Jo HS, Joo K, Kabir ML, Keller D, Khachatryan M, Khanal A, Khandaker M, Kim W, Klein FJ, Kubarovsky V, Kuhn SE, Lanza L, Laskaris G, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Markov N, McKinnon B, Mey-Tal Beck S, Mirazita M, Mokeev V, Montgomery RA, Movsisyan A, Munoz Camacho C, Mustapha B, Nadel-Turonski P, Niccolai S, Niculescu G, Osipenko M, Ostrovidov AI, Paolone M, Paremuzyan R, Park K, Pasyuk E, Patsyuk M, Phelps W, Pogorelko O, Prok Y, Protopopescu D, Ripani M, Rizzo A, Rosner G, Rossi P, Sabatié F, Schmookler BA, Schumacher RA, Sharabian Y, Skorodumina I, Sokhan D, Sparveris N, Stepanyan S, Strauch S, Taiuti M, Tan JA, Tyler N, Ungaro M, Voskanyan H, Voutier E, Wang R, Wei X, Wood MH, Zachariou N, Zhang J, Zhao ZW, Zheng X. Direct Observation of Proton-Neutron Short-Range Correlation Dominance in Heavy Nuclei. PHYSICAL REVIEW LETTERS 2019; 122:172502. [PMID: 31107086 DOI: 10.1103/physrevlett.122.172502] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 03/11/2019] [Indexed: 06/09/2023]
Abstract
We measured the triple coincidence A(e,e^{'}np) and A(e,e^{'}pp) reactions on carbon, aluminum, iron, and lead targets at Q^{2}>1.5 (GeV/c)^{2}, x_{B}>1.1 and missing momentum >400 MeV/c. This was the first direct measurement of both proton-proton (pp) and neutron-proton (np) short-range correlated (SRC) pair knockout from heavy asymmetric nuclei. For all measured nuclei, the average proton-proton (pp) to neutron-proton (np) reduced cross-section ratio is about 6%, in agreement with previous indirect measurements. Correcting for single-charge exchange effects decreased the SRC pairs ratio to ∼3%, which is lower than previous results. Comparisons to theoretical generalized contact formalism (GCF) cross-section calculations show good agreement using both phenomenological and chiral nucleon-nucleon potentials, favoring a lower pp to np pair ratio. The ability of the GCF calculation to describe the experimental data using either phenomenological or chiral potentials suggests possible reduction of scale and scheme dependence in cross-section ratios. Our results also support the high-resolution description of high-momentum states being predominantly due to nucleons in SRC pairs.
Collapse
|
145
|
Mauro T, Celli A, Cho R, Lambert W, Park K, Pitchford M, Gordon M, Lee E, Tsai K, Cleaver J, Arron S. 504 CERKL expression enhances survival in cutaneous squamous cell carcinoma. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
146
|
Shin K, Kim K, Cho Y, Ikushiro H, Yano T, Holleran W, Park K, Uchida Y. 298 Both sphingosine kinase 1 and 2 coordinately regulate cathelicidin antimicrobial peptide production during keratinocyte differentiation. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
147
|
Shin K, Yoon S, Jung J, Hwang E, Jeong S, Chung H, Park K. 466 Stimulation of autophagy attenuated Propionibacterium acnes-induced inflammatory responses in cultured skin cells. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
148
|
Shin K, Park K, Jeong S, Park B, Uchida Y, Wakefield J, Crumrine D, Meyer J, Elias P. 647 Basis for the link between atopic dermatitis and autism. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
149
|
Owonikoko T, Kim H, Govindan R, Ready N, Reck M, Peters S, Dakhil S, Navarro A, Rodriguez-Cid J, Schenker M, Lee J, Gutierrez V, Percent I, Morgensztern D, Fairchild J, Baudelet C, Park K. Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz094] [Citation(s) in RCA: 64] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
|
150
|
Le T, Park J, Jeon Y, Park K, Hong K, Cho S. 03:27 PM Abstract No. 96 Prevalence of May-Thurner variants in patients with symptomatic May-Thurner syndrome. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|